🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the best dose and side effects of siltuximab...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2020-01-17
Trial ID
NCT04191421
Treatments Being Tested
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Unknown
Location
Massachusetts General Hosital Cancer Center
Start Date
2018-10-15
Trial ID
NCT03668431
Treatments Being Tested
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
The purpose of this study is to find out whether a drug called PDR001, comb...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-09-02
Trial ID
NCT04544111
Treatments Being Tested
The purpose of this study of capmatinib (INC280) and spartalizumab (PDR001)...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-15
Trial ID
NCT02795429
Treatments Being Tested
This clinical trial is studying the drug Ribociclib (LEE011) in combination...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2017-11-08
Trial ID
NCT03294694
Treatments Being Tested
The purpose of this study was to evaluate safety and efficacy of the combin...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2017-02-17
Trial ID
NCT02967692
Treatments Being Tested
The purpose of this randomized controlled Phase II study is to assess the e...
Status
Completed
Location
Northwest Georgia Oncology Center NWGA Onc - Carrollton
Start Date
2016-04-20
Trial ID
NCT02605967
Treatments Being Tested
A two part study to determine the maximum tolerated dose and/or recommended...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2017-04-20
Trial ID
NCT02988440